- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
Clinical trial condition
Immunoblastic Lymphadenopathy
Explore clinical trials studying Immunoblastic Lymphadenopathy. Study availability and eligibility vary by location and protocol.
192 public trials
11 recruiting studies
Immunoblastic Lymphadenopathy trial results
NCT00005804
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
Active, Not Recruiting
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
NCT01787409
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +40 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
Active, Not Recruiting
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
NCT00544115
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +95 more
- Locations
-
Not specified
Active, Not Recruiting
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
NCT03598998
- Conditions
- Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
Active, Not Recruiting
A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
NCT06035497
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +26 more
- Locations
-
- Local Institution - 0031 Anjo-shi, Aichi-ken, Japan
- Local Institution - 0011 Nagoya, Aichi-ken, Japan
- Local Institution - 0024 Toyohashi, Aichi-ken, Japan
- Local Institution - 0017 Kamogawa, Chiba, Japan
Active, Not Recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
Study of Pembrolizumab (MK-3475) in Combination With Romidepsin
NCT03278782
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas
NCT02223208
- Conditions
- ALK- Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-cell Lymphoma (AITL), Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Ospedale SS. Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
- Policlinico S. Orsola Malpighi Bologna, BO, Italy
- Spedali Civili Brescia, BS, Italy
- Ospedale Businco Cagliari, CA, Italy